SCHEMBL4385103

SCHEMBL4385103

Cn1cc(/C=C2\Oc3cc(O)cc(O)c3C2=O)c2c(-c3cncnc3)ccnc21

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 18/20 0.82
PIK3CA P42336 17/20 0.82
CHUK O15111 1/20 0.55
ABL1 P00519 1/20 0.55
CDK1 P06493 1/20 0.55
LYN P07948 1/20 0.55
MET P08581 1/20 0.55
HCK P08631 1/20 0.55
FGFR1 P11362 1/20 0.55
SRC P12931 1/20 0.55
PDGFRA P16234 1/20 0.55
PRKCA P17252 1/20 0.55
CDK2 P24941 1/20 0.55
MAPK1 P28482 1/20 0.55
KDR P35968 1/20 0.55
MAPKAPK2 P49137 1/20 0.55
GSK3A P49840 1/20 0.55
GSK3B P49841 1/20 0.55
MAP4K2 Q12851 1/20 0.55
ROCK1 Q13464 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4287884 1.00 MTOR (0.82) MTORPIK3CACHUKABL1CDK1
SCHEMBL4287914 0.93 MTOR (0.85) MTORPIK3CACHUKABL1CDK1
SCHEMBL4390964 0.93 MTOR (0.85) MTORPIK3CACHUKABL1CDK1
SCHEMBL4389984 0.91 MTOR (0.88) MTORPIK3CACHUKABL1CDK1
SCHEMBL4278450 0.91 MTOR (0.88) MTORPIK3CACHUKABL1CDK1
SCHEMBL3228222 0.90 MTOR (1.00) MTORPIK3CACHUKABL1CDK1
SCHEMBL3228206 0.90 MTOR (1.00) MTORPIK3CACHUKABL1CDK1
SCHEMBL4385683 0.89 MTOR (0.85) MTORPIK3CACHUKABL1CDK1
SCHEMBL4285785 0.89 MTOR (0.85) MTORPIK3CACHUKABL1CDK1
SCHEMBL4379383 0.89 MTOR (0.78) MTORPIK3CACHUKABL1CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090298820-A1 3-SUBSTITUTED-1H-PYRROLO[2,3-B]PYRIDINE AND 3-SUBSTITUTED-1H-PYRROLO[3,2-B]PYRIDINE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES WYETH (US) 2009-12-03 US claimed
US-20090298820-A1 3-SUBSTITUTED-1H-PYRROLO[2,3-B]PYRIDINE AND 3-SUBSTITUTED-1H-PYRROLO[3,2-B]PYRIDINE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES WYETH (US) 2009-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298820-A1 3-SUBSTITUTED-1H-PYRROLO[2,3-B]PYRIDINE AND 3-SUBSTITUTED-1H-PYRROLO[3,2-B]PYRIDINE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES MTOR, PIK3CA, PIK3C2B MTOR 1/4885PIK3CA 2/4885CHUK 219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.